- LATEST
- WEBSTORY
- TRENDING
INDIA
67.6% of adults found seropositive, 40 crore susceptible to COVID-19: Sero survey
The survey conducted on 29,000 people says that more than two-thirds of Indians above six years of age have developed antibodies against COVID-19.
Updated : Jul 21, 2021, 12:06 PM IST | Edited by : Shampa Sen
 "40 crore Indians susceptible to COVID-19")
TRENDING NOW
)
Kanguva box office collection Day 3: Suriya, Bobby Deol's film shows slight growth after massive drop, earns Rs 42 crore
)
This Pakistani Influencer's private video leaked online, days after Minahil Malik and Insha Rehman's clips
)
Meet star with no hit films, still earns Rs 5 lakh a month, is more famous than Aishwarya, Amitabh, Kareena, Ram Charan
)
Meet actress who worked as sweeper, did superhit film with Shah Rukh, took up acting after Madhuri Dixit..., earns Rs..
)
'I sort of...': Aishwarya Rai's 'enjoyed every phase and moved on' statement amid divorce rumours with Abhishek Bachchan
)
Shilpa Shetty breaks down, Salman Khan cancels shoot; celebs rush to Lilavati hospital after Baba Siddique shot dead
)
'What's the fuss about': Amid divorce rumours with Abhishek, Aishwarya Rai talks about losing weight in viral video
)
Mukesh Ambani's SUPERHIT offer for Jio users: Get unlimited validity for 84 days at just Rs...
)
'Jaya Bachchan, is that you?': Mukesh Khanna loses cool as he asks paps to keep quiet, netizens roast him in return
)
India's highest paid actor charges Rs 300 crore for a film; more than Vijay, Shah Rukh, Prabhas, Rajini, Ranbir, Salman
)
'Miyan biwi toh...': Nikhil Dwivedi BREAKS silence on Abhishek Bachchan, Aishwarya Rai's behaviour amid divorce rumours
)
Amid Abhishek Bachchan and Aishwarya Rai divorce rumours, Jaya Bachchan surprises everyone with...
)
Allu Arjun gave Salman Khan, Shah Rukh Khan their biggest hits by rejecting films that together earned Rs 2000 crore
)
Aishwarya Rai's most expensive possessions: Dubai mansion worth Rs.., 5BHK bungalow in Bandra, wedding saree worth Rs..
)
'I am very hurt': Amid Aishwarya Rai, Abhishek Bachchan's divorce rumours, his confession to 'daughter' goes viral
According to the latest nationwide serological survey, about 40 crore people in the country are susceptible to COVID-19. This is the fourth such exercise to have been conducted in the country. The survey report says that more than two-thirds of Indians above six years of age have developed antibodies against COVID-19.
This means two-thirds of the Indian population above the age of six have already been infected with the coronavirus. Meanwhile, some experts have said a third wave could hit children in the country.
The fourth such survey, conducted in the last two weeks of June and the first week of July across 70 districts in 21 states, revealed seropositivity or the presence of antibodies in the blood serum among 67.6% of the sampled population against SARS-CoV-2, which causes COVID-19.
India's daily cases have fallen to four-month lows after a second wave that crippled the healthcare system. But experts have warned the authorities against swiftly reopening cities and voiced concerns about overcrowding at tourist sites.
Data from serological survey
Two-thirds of India's population have antibodies against the coronavirus, according to data released on Tuesday.
The survey of 29,000 people across the nation was conducted in June and July of this year.
The fourth national blood serum survey which tests for antibodies, known as a serosurvey, included 8,691 children aged 6-17 years for the first time. Half of them were seropositive.
The survey showed 67.6% of adults were seropositive, while more than 62% of adults were unvaccinated.
As of July, just over 8% of eligible adult Indians had received two vaccine doses.
About 400 million of India's 1.4 billion people did not have antibodies, the survey showed.
The study also surveyed 7,252 healthcare workers and found 85% had antibodies, with one in 10 unvaccinated.
Last month, data showed at least half of under-18s in India's financial capital of Mumbai were exposed to COVID-19 and had antibodies against it.
